HOME >> MEDICINE >> NEWS
OHSU researchers discover protein fragment that helps predict breast cancer outcome

Oregon Health & Science University Cancer Institute researchers have identified a protein fragment in some human breast cancers that may help predict a patient's chances of survival.

The presence of the fragment, called p95HER-2, in breast cancer tissue correlates closely with lymph node metastasis and earlier recurrence of the disease, suggesting that p95HER-2 is a marker and perhaps even involved in metastasis.

"By studying this marker we have a better chance to identify the patients who are more likely to have a longer disease-free survival," said Edward Keenan, Ph.D., one of the authors of the study. Keenan is professor of physiology and pharmacology and associate dean for medical education, OHSU School of Medicine.

The study, conducted in the lab of Gail Clinton, Ph.D., professor of biochemistry and molecular biology, OHSU School of Medicine, in collaboration with Keenan and investigators in Spain led by Jose Baselga, M.D., will be published on Jan. 15 in Clinical Cancer Research, a journal published by the American Association for Cancer Research.

The study builds on observations the investigators have published over the last five years about the role of the HER-2 oncogene in breast cancer. HER-2, a growth factor receptor, is overexpressed in 20 to 30 percent of breast cancer cases, but it has had limited usefulness in predicting clinical outcomes, particularly in early-stage breast cancer.

Clinton's lab identified a fragment of full-length p185HER-2 that results from HER-2 cleavage, called p95HER-2, and developed an antibody that recognized it, making it possible to study the role of p95HER-2 in the spread of breast cancer.

The researchers studied breast cancer tissue from 483 biopsies from hospitals in the United States and Spain representing all stages of the disease. Two forms of the HER-2 protein were investigated: the full-length p185HER-2 receptor and its truncated form, p95HER-2. Only the truncated for
'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503-494-8231
Oregon Health & Science University
15-Jan-2006


Page: 1 2

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
3. Penn researchers discover novel pathway for increasing good cholesterol
4. Theory of facial aging gets a facelift from UT Southwestern researchers
5. UIC researchers to develop new drugs to fight bioterrorism
6. UQ researchers discover some of the oldest forms of life
7. U of M researchers discover new method to combat HIV
8. U of M researchers assess effectiveness of computerized physician order entry system
9. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
10. Physician-researchers often less successful in obtaining NIH funding
11. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2019)... ... June 13, 2019 , ... The Stevie® Awards, organizer ... deadline in the 2019 competition is extended to July 18. The original final ... awards program, The IBAs attract nominations from organizations in more than 70 nations ...
(Date:6/13/2019)... ... June 13, 2019 , ... GlycoMark, Inc. announced a new ... Diabetes Association (ADA) Scientific Sessions 2019 involving the GlycoMark test being used for ... SGLT-2 inhibitors are used to lower glucose levels in patients with diabetes by ...
(Date:6/12/2019)... ... June 12, 2019 , ... Learn how to succeed in ... innovative branding and network with others in this growing field. , What are ... manufacturers and others who are part of the rapidly evolving cannabis industry will ...
(Date:6/12/2019)... , ... June 12, 2019 , ... ... the newest addition to the family of Best Sanitizers’ HACCP Footwear Sanitizing Unit ... processing facilities, nutraceutical plants, pharmaceutical plants, clinical research labs, and clean rooms by ...
(Date:6/11/2019)... ... June 11, 2019 , ... The FSH Society today announced ... government regulators, biopharma companies, and academic thought leaders to discuss the current state ... is the world’s largest research-focused patient advocacy organization for FSHD, a hereditary muscle-damaging ...
Breaking Medicine News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... The National ... NCCN Chemotherapy Order Templates ( NCCN Templates ®) into the CureMD Oncology EHR ... the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). , “The collaboration with ...
(Date:6/6/2019)... ... ... MEDICC (Medical Education Cooperation with Cuba) has deplored the Trump administration’s decision ... more assault on the freedom of Americans, Cuban-Americans and the health and livelihoods of ... Directors. , MEDICC has long stood for open dialogue and cooperation with Cuban ...
(Date:6/6/2019)... ... 05, 2019 , ... Cobb-Vantress, Inc. / Siloam Springs, Arkansas, ... avian influenza virus from replicating in lab-grown chicken cells, suggesting that it may ... The study was funded by Biotechnology and Biological Sciences Research Council with additional ...
Breaking Medicine Technology:
Cached News: